Evonik has reported 1% organic sales growth to EUR3.2bn (US$4bn) and EBITDA better than previous quarters at EUR501m.

For the first nine months of 2014, Evonik posted 2% organic sales growth to around EUR9.7bn and adjusted EBITDA at EUR1.4bn, but below the good prior-period, level due to what the company terms "prices."
 
"Evonik did well in an increasingly difficult economic environment," said Evonik chairman, Klaus Engel. "There has been a clear upward trend in operating earnings this year and in the third quarter they were only slightly below the prior-period level.

"Demand for our products was good despite slower global growth.

Show the press release

Essen, October 30, 2014

Company information

Evonik, the creative industrial group from Germany, is one of the world leaders 
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. 

Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.7 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.

Original source: http://corporate.evonik.com/en/media/press_releases/pages/news-details.aspx?newsid=47478

Auto market intelligence
from just-auto

• Auto component fitment forecasts
• OEM & tier 1 profiles & factory finder
• Analysis of 30+ auto technologies & more